Skip to main content
. Author manuscript; available in PMC: 2021 May 25.
Published in final edited form as: Breast Cancer Res Treat. 2018 Nov 7;173(3):701–708. doi: 10.1007/s10549-018-5028-z

Table 4.

Patient symptom questionnaire (n = 66*) responses by SV cohort with symptoms categorized as none, mild, moderate, or severe

Symptom None, N (%) Mild, N (%) Moderate, N (%) Severe, N (%)
Fatigue 14 (22) 36 (56) 11 (17) 3 (5)
Sleep difficulty 20 (30) 24 (36) 15 (23) 7 (11)
Weight changes 25 (38) 21 (32) 16 (25) 3 (5)
Numbness or tingling 25 (38) 20 (31) 15 (23) 5 (8)
Muscle aches 27 (41) 21 (32) 16 (24) 2 (3)
Pain 32 (50) 20 (31) 7 (11) 5 (8)
Weakness or decreased mobility 34 (53) 19 (30) 9 (14) 2 (3)
Hot flashes 37 (58) 13 (20) 10 (16) 4 (6)
 Only patients pre-menopausal at DX 26 (79) 4 (12) 3 (9) 0 (0)
Memory decline 38 (58) 20 (30) 5 (8) 3 (5)
Menstrual changes 39 (80) 2 (4) 4 (8) 4 (8)
 Only patients pre-menopausal at DX 24 (100) 0 (0) 0 (0) 0 (0)
Vaginal dryness 40 (63) 12 (19) 8 (13) 3 (5)
Sexuality changes 41 (69) 7 (12) 8 (14) 3 (5)
Difficulty working 43 (72) 10 (17) 4 (7) 3 (5)
Difficulty with family relations 53 (82) 7 (11) 4 (6) 1 (2)
Fertility concerns 54 (95) 2 (4) 1 (2) 0 (0)
*

For 21 patients no questionnaire data were available